Healex is a Germany-based startup that aims to bridge the gap between clinical research and clinical care through seamless structured clinical data solutions. The company provides SaaS, on-premises enterprise software, and web applications designed to accelerate and improve clinical research and trial management. Healex's platforms allow for rapid integration of high-quality, real-time structured clinical data across multiple sites, aligning with the FHIR data standard and facilitating the transition to a FHIR-based healthcare industry. One of the key strengths of Healex is its ability to support international, open medical data standards, making it easier for various entities within the healthcare ecosystem to utilize clinical data for a wide range of applications. The company's software has been proven by over 6300 researchers at 340 hospitals and across 3000+ studies, highlighting its effectiveness and relevance in the clinical research field. Since its establishment in 2019, Healex has positioned itself as a pivotal player in the Information Technology sector, addressing crucial challenges in clinical data management and research. The startup's commitment to enhancing the efficiency and efficacy of multi-site clinical trials makes it an appealing investment opportunity for venture capitalists looking to support impactful innovations in the healthcare and research industries.
There is no investment information
No recent news or press coverage available for Healex.